.After antibody-drug conjugate (ADC) professional Seagen was actually marketed to Pfizer in 2015 for...
.On the heels of a phase 3 succeed that failed to impress investors, Ironwood Pharmaceuticals is bac...
.Do not cease Monte Rosa Therapeutics currently. The Boston-based biotech is enjoying after authoriz...
.Invite to this week's Chutes & Ladders, our summary of considerable management hirings, shooting...
.Celebrating his firm's upsized going public (IPO), Septerna chief executive officer Jeffrey Finer s...
.AbbVie has gone back to the source of its own antipsychotic giant Vraylar looking for yet another h...
.GenSight Biologics is full weeks far from lacking cash. Once again. The biotech just possesses enou...
.Monopar Therapies is recouping a medication coming from the dump of AstraZeneca's unusual disease p...
.Along with brand new data out on Arcus Biosciences' speculative HIF-2a prevention, one team of prof...
.After creating a genetics treatment partnership with Dyno Therapeutics in 2020, Roche is actually b...